SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52 | -59.7% | 87,000 | -12.4% | 0.00% | -66.7% |
| Q2 2023 | $129 | +95.5% | 99,352 | +163.5% | 0.00% | +200.0% |
| Q1 2023 | $66 | -40.5% | 37,710 | +5.9% | 0.00% | -50.0% |
| Q4 2022 | $111 | -99.9% | 35,620 | -18.8% | 0.00% | -66.7% |
| Q3 2022 | $214,000 | +336.7% | 43,877 | +264.2% | 0.01% | +500.0% |
| Q2 2022 | $49,000 | -25.8% | 12,048 | +5.9% | 0.00% | -50.0% |
| Q1 2022 | $66,000 | +127.6% | 11,376 | +242.1% | 0.00% | +100.0% |
| Q3 2021 | $29,000 | -25.6% | 3,325 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | -2.5% | 3,275 | +0.6% | 0.00% | 0.0% |
| Q1 2021 | $40,000 | -21.6% | 3,255 | -0.5% | 0.00% | 0.0% |
| Q4 2020 | $51,000 | +363.6% | 3,270 | +171.6% | 0.00% | – |
| Q3 2020 | $11,000 | – | 1,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |